News & Perspective

Oct 03, 2017

Oct 03, 2017

News Scan for Oct 03, 2017

Saudi MERS case
Measles in the US
Pup-borne Campylobacter
H5N8 outbreaks
VHF vaccine contract
Kidney injury and antibiotics

Jun 30, 2017

Jun 30, 2017

ASP Scan (Weekly) for Jun 30, 2017

Students' antibiotic knowledge
MCR-1 in Portugal
Opposition to AMR budget cuts
Antibiotics for skin wounds
Antibiotic resistance at the Hajj
C diff in cancer patients
Contact precautions for MRSA
Antibiotic-resistant acne

Nov 24, 2014

Nov 24, 2014
Ebola vaccine shot

NewLink, Merck deal boosts prospects for Ebola vaccine

The small biotech and the drug giant announced an agreement today.

Nov 15, 2007

Nov 15, 2007

THE PANDEMIC VACCINE PUZZLE Can we vaccinate enough people in time to matter?

Maryn McKennaContributing Writer

(CIDRAP News) – This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

Feb 28, 2006

Feb 28, 2006

Avian flu suspected in ducks in Sweden, cat in Germany

(CIDRAP News) – Europe braced for further spread of the H5N1 avian influenza virus today in the wake of reports that the virus was suspected in the deaths of two wild ducks on Sweden's Baltic coast and a domestic cat in Germany.

The cat was discovered last weekend on Ruegen, the island off Germany's north coast where H5N1 was first discovered on German soil, according to a Reuters report.

Oct 28, 2005

Oct 28, 2005

Chiron wins H5N1 vaccine contract; WHO says virus is changing

(CIDRAP News) – The US government has awarded Chiron Corp. a $62.5 million contract to make a vaccine for H5N1 avian influenza as part of efforts to prepare for a possible human flu pandemic.

Nov 17, 2004

Nov 17, 2004

Clinical trials of human H5N1 flu vaccine to start soon

(CIDRAP News) – Clinical trials of a vaccine designed to keep the H5N1 avian influenza virus from sparking a human flu pandemic will begin early in 2005, the head of the National Institute of Allergy and Infectious Diseases (NIAID) said this week.

Sort Results

 

Narrow results

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3M Gilead 
Grant support for ASP provided by

  Become an underwriter»